<DOC>
	<DOC>NCT01072058</DOC>
	<brief_summary>The purpose of this study is to determine possible alterations in cardiac function in patients with Rheumatoid Arthritis and Ankylosing Spondylitis under anti-TNF therapy, without clinical heart disfunction at baseline, using highly sensitive non-invasive methods.</brief_summary>
	<brief_title>Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis, Ankylosing</mesh_term>
	<mesh_term>Natriuretic Peptide, Brain</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Diagnosis of Rheumatoid Arthritis eligible to receive TNF blockers Diagnosis of Ankylosing Spondylitis eligible to receive TNF blockers Clinical heart failure Chagas'disease Stable or unstable angina Past history of myocardial infarct Systemic Ã¡rterial hypertension (grade 3) Valvulopathy Chronic kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Infliximab</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>Etanercept</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Diastolic disfunction</keyword>
	<keyword>TNF blocker</keyword>
	<keyword>Anti-TNF</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Tissue doppler imaging</keyword>
	<keyword>Brain Natriuretic Peptide</keyword>
	<keyword>NT-proBNP</keyword>
</DOC>